What Researchers Did
The author reviewed the local care and medical treatment options for diabetic foot ulcers that have poor blood supply.
What They Found
This review article covers treatment of ischemic diabetic ulcers and says optimal medical treatment is multifactorial. It reports that infection is very common, and that care depends on telling limb-threatening or life-threatening infections from non-limb-threatening ones. Oral antibiotics such as amoxicillin/clavulanate or clindamycin can be used for non-limb-threatening infection, while severe infection calls for broader-spectrum intravenous antibiotics. Granulocyte colony-stimulating factor as an add-on for limb-threatening infection is associated with a lower rate of amputation. Iloprost improves ulcer healing, decreases pain, and slightly lowers the rate of amputation. The abstract says systemic hyperbaric oxygen therapy can perhaps improve clinical outcome, but additional research is needed to define its specific indications and benefits. It also says the place of topical growth factor and living skin equivalents is not defined, and that local care is not rationalized and depends on local habits.
What This Means for Canadian Patients
For people with diabetic foot ulcers and poor circulation, the abstract describes many parts of care, including infection control, improving blood flow, debridement, dressings, edema treatment and reducing plantar pressure. On hyperbaric oxygen, it only says it can perhaps improve outcome and that its specific indications and benefits still need to be defined. Patients should talk with their care team about which options fit their situation.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a narrative overview with no reported patient numbers or new data, and the abstract itself states that local care is not rationalized and that the roles of several treatments, including hyperbaric oxygen, are not yet defined.